Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
0.719
-0.018 (-2.49%)
At close: Apr 28, 2026, 4:00 PM EDT
0.698
-0.022 (-3.00%)
Pre-market: Apr 29, 2026, 6:14 AM EDT
Genenta Science Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -6.53 | -8.91 | -11.65 | -8.48 | -5.53 | |
| Depreciation & Amortization | 0.03 | 0.04 | 0.04 | 0.01 | 0 | |
| Loss (Gain) From Sale of Investments | 0.1 | - | - | - | - | |
| Stock-Based Compensation | 1.01 | 0.85 | 0.74 | 0.72 | 0.5 | |
| Other Operating Activities | 0.1 | 0.06 | 0.08 | 0.09 | 0.01 | |
| Change in Accounts Payable | 1.31 | 0.03 | -0.73 | 1 | -0.37 | |
| Change in Other Net Operating Assets | -2.89 | 1.69 | 0.31 | -0.76 | -1.58 | |
| Operating Cash Flow | -6.87 | -6.24 | -11.21 | -7.42 | -6.96 | |
| Capital Expenditures | -0.01 | -0 | -0.01 | -0.03 | -0.01 | |
| Investment in Securities | -14.54 | 6.89 | -14.88 | - | - | |
| Investing Cash Flow | -14.54 | 6.88 | -14.89 | -0.03 | -0.01 | |
| Long-Term Debt Issued | 7.5 | - | - | - | - | |
| Net Debt Issued (Repaid) | 7.5 | - | - | - | - | |
| Issuance of Common Stock | - | - | - | - | 28.74 | |
| Other Financing Activities | 14.79 | 0.27 | 0 | - | - | |
| Financing Cash Flow | 22.29 | 0.27 | 0 | - | 28.74 | |
| Foreign Exchange Rate Adjustments | 0.07 | -0.02 | -0.01 | - | - | |
| Net Cash Flow | 0.95 | 0.89 | -26.1 | -7.45 | 21.77 | |
| Free Cash Flow | -6.88 | -6.24 | -11.22 | -7.45 | -6.97 | |
| Free Cash Flow Per Share | -0.35 | -0.34 | -0.62 | -0.41 | -0.46 | |
| Levered Free Cash Flow | -3.1 | -4.18 | -7.57 | -5.56 | -4.72 | |
| Unlevered Free Cash Flow | -3.1 | -4.18 | -7.57 | -5.56 | -4.71 | |
| Change in Working Capital | -1.58 | 1.72 | -0.42 | 0.24 | -1.94 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.